- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03601442
Managed Access Programs for CTL019, Tisagenlecleucel
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
CCTL019B2003I - Available - Managed Access Program (MAP) to provide access to patients with out-of-specification (OOS) leukapheresis product and/or OOS manufactured CTL019
CCTL019B2004I - Available - Managed Access Program (MAP) to provide access to reinfusion for approved indications
CCTL019A02001I - Available - Managed Access Program (MAP) to provide access to CLT019 in off-label indications
Study Type
Expanded Access Type
- Individual Patients
- Intermediate-size Population
Contacts and Locations
Study Locations
-
-
Western Australia
-
Murdoch, Western Australia, Australia, 6150
- Available
- Novartis Investigative Site
-
-
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X8
- Available
- Novartis Investigative Site
-
-
Quebec
-
Montreal, Quebec, Canada, H1T 2M4
- Available
- Novartis Investigative Site
-
-
-
-
Arizona
-
Gilbert, Arizona, United States, 85234
- Available
- Banner MDACC
-
Phoenix, Arizona, United States, 85016
- Available
- Phoenix Children's Hospital
-
Phoenix, Arizona, United States, 85004
- Available
- University of Arizona Cancer Center
-
Phoenix, Arizona, United States, 85006
- Available
- Banner University of Arizona Medical Center
-
Phoenix, Arizona, United States, 85016
- Available
- Phoenix Childrens Hospital
-
Tucson, Arizona, United States, 85724
- Available
- Banner Uni Medical Center Tucson
-
-
California
-
Duarte, California, United States, 91010 3000
- Available
- City of Hope National Medical Center Hematology&HematCellTransplant
-
Duarte, California, United States, 91010
- Available
- City Of Hope
-
Los Angeles, California, United States, 90027
- Available
- Children's Hospital Los Angeles CRFB002H2301
-
Los Angeles, California, United States, 90027
- Available
- Children's Hospital Los Angeles
-
Los Angeles, California, United States, 90027
- Available
- Childrens Hospital Los Angeles
-
Los Angeles, California, United States, 90095
- Available
- Mattel Childrens Hospital UCLA
-
Los Angeles, California, United States, 90095
- Available
- University of California at Los Angeles UCLA
-
Palo Alto, California, United States, 94304
- Available
- Lucile Packard Children s Hospital Stanford University
-
Palo Alto, California, United States, 94304
- Available
- Lucile Packard Childrens Hospital
-
Palo Alto, California, United States, 94304
- Available
- Stanford University Medical Center
-
San Diego, California, United States, 92093-0979
- Available
- UC San Diego
-
San Diego, California, United States, 92103
- Available
- University of California at San Diego, Moores Cancer Ctr UCSD
-
San Diego, California, United States, 92123
- Available
- Rady Children s Hospital Dept of Oncology
-
San Diego, California, United States, 92123
- Available
- Rady Childrens Hospital
-
San Francisco, California, United States, 94143
- Available
- Ucsf Benioff Childrens Hospital Pediatric Hematology Oncology
-
San Francisco, California, United States, 94143
- Available
- University of Califronia San Francisco
-
Santa Monica, California, United States, 90904
- Available
- University of California, Los Angeles
-
Stanford, California, United States, 94304
- Available
- Stanford Healthcare
-
-
Colorado
-
Denver, Colorado, United States, 80218
- Available
- Children's Hospital Colorado
-
-
Connecticut
-
New Haven, Connecticut, United States, 06520
- Available
- Yale Cancer Center
-
-
Florida
-
Miami, Florida, United States, 33136
- Available
- University of Miami Hospital
-
St. Petersburg, Florida, United States, 33701
- Available
- JHMI All Children s Hospital
-
-
Georgia
-
Atlanta, Georgia, United States, 30342
- Available
- Northside Hospital
-
Atlanta, Georgia, United States, 30322
- Available
- Emory University School of Medicine Emory University (12)
-
Atlanta, Georgia, United States, 30322
- Available
- Emory University School of Medicine/Winship Cancer Institute Winship Cancer Center
-
Atlanta, Georgia, United States, 30322
- Available
- Emory University School of Medicine/Winship Cancer Institute
-
Atlanta, Georgia, United States, 30342
- Available
- Children's Healthcare of Atlanta Cellular Therapies Lab
-
-
Illinois
-
Chicago, Illinois, United States, 60637
- Available
- University of Chicago
-
Chicago, Illinois, United States, 60611
- Available
- Ann and Robert H Lurie Childrens Hospital of Chicago
-
Chicago, Illinois, United States, 60611
- Available
- Northwestern
-
Chicago, Illinois, United States, 60612
- Available
- University of Illinois at Chicago
-
Chicago, Illinois, United States, 60637-1470
- Available
- University of CHicago Comer Children's Hospital Regulatory
-
-
Kentucky
-
Louisville, Kentucky, United States, 40217
- Available
- Healthwatch Plaza Research Associates
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- Available
- University of Maryland Medical Center
-
Baltimore, Maryland, United States, 21201
- Available
- University of Maryland Medical Center UMMC
-
Baltimore, Maryland, United States, 21201
- Available
- University of Maryland
-
Baltimore, Maryland, United States, 21287
- Available
- Johns Hopkins Outpatient Center
-
Baltimore, Maryland, United States, 21287
- Available
- Johns Hopkins University Hospital
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Available
- Massachusetts General Hospital
-
Boston, Massachusetts, United States, 02215
- Available
- Dana-Farber Cancer Institute
-
Boston, Massachusetts, United States, 02215
- Available
- Dana Farber Cancer Institute
-
Boston, Massachusetts, United States, 02111
- Available
- Tufts Medical Center
-
Boston, Massachusetts, United States, 02114
- Available
- Massachusetts General Hospital Cancer Center
-
Boston, Massachusetts, United States, 02114
- Available
- Massachusetts General Hospital DF/HCC institutions
-
Boston, Massachusetts, United States, 02114
- Available
- MGH Cancer Center MGH Cancer Center
-
Boston, Massachusetts, United States, 02114
- Available
- MGH Cancer Center
-
Boston, Massachusetts, United States, 02215
- Available
- Dana Farber Cancer Institute Dana Farber Cancer Institute
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109-2800
- Available
- University of Michigan IRB
-
Ann Arbor, Michigan, United States, 48109-5848
- Available
- University of Michigan Medical Center
-
Ann Arbor, Michigan, United States, 48109
- Available
- University of Michigan Health System
-
Detroit, Michigan, United States, 48201
- Available
- Karmanos Cancer Institute
-
Detroit, Michigan, United States, 48201
- Available
- Moffitt Cancer Center
-
Detroit, Michigan, United States, 48201
- Available
- Wayne State University - Karmanos Cancer Institute
-
Detroit, Michigan, United States, 48202 2689
- Available
- Henry Ford Hospital Henry Ford
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55455
- Available
- University of Minnesota
-
Minneapolis, Minnesota, United States, 55455
- Available
- University of Minnesota Masonic Childrens Hospital
-
Rochester, Minnesota, United States, 55905
- Available
- Mayo Clinic
-
-
Missouri
-
St Louis, Missouri, United States, 63110
- Available
- WUSTL Jewish Barnes
-
-
New Jersey
-
Hackensack, New Jersey, United States, 07601
- Available
- Hackensack University Medical Center Hackensack UMC
-
Hackensack, New Jersey, United States, 07601
- Available
- Hackensack University Medical Center Onc Dept
-
New Brunswick, New Jersey, United States, 08901
- Available
- Robert Wood Johnson Medical School
-
New Brunswick, New Jersey, United States, 08903
- Available
- Rutgers Cancer Institute of New Jersey
-
-
New York
-
Buffalo, New York, United States, 14263
- Available
- Roswell Park Cancer Institute Rosewell
-
Buffalo, New York, United States, 14263
- Available
- Roswell Park Cancer Institute
-
New York, New York, United States, 10065
- Available
- Memorial Sloan Kettering Cancer Center
-
New York, New York, United States, 10017
- Available
- Memorial Sloan Kettering
-
New York, New York, United States, 10021
- Available
- Memorial Sloan Kettering Cancer Center Mskcc
-
New York, New York, United States, 10021
- Available
- Memorial Sloan Kettering Cancer Center Oncology
-
New York, New York, United States, 10032
- Available
- Columbia University Medical Center New York Presbyterian CUMC Research Pharmacy
-
New York, New York, United States, 10032
- Available
- Columbia University Medical Center New York Presbyterian Neuroendocrine Unit
-
New York, New York, United States, 10065
- Available
- Memorial Sloan Kettering Cancer Center MSKCC (9)
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27514
- Available
- University of North Carolina Chapel Hill Physician Office Building
-
Chapel Hill, North Carolina, United States, 27599
- Available
- University of North Carolina Health System
-
Charlotte, North Carolina, United States, 28203
- Available
- Atrium Heath
-
Durham, North Carolina, United States, 27710
- Available
- Duke University Medical Center
-
Durham, North Carolina, United States, 27710
- Available
- Duke University Medical Center Dept. of DUMC (4)
-
-
Ohio
-
Cincinnati, Ohio, United States, 45229-3039
- Available
- Cincinnati Children s Hospital Medical Center
-
Cincinnati, Ohio, United States, 45229
- Available
- Cincinnati Childrens Hospital
-
Cincinnati, Ohio, United States, 45242
- Available
- Oncology Hematology Care Inc Drug Shipment
-
Cleveland, Ohio, United States, 44106-5028
- Available
- University Hospitals Cleveland Medical Center Univ. Hospitals of Cleveland
-
Columbus, Ohio, United States, 43205
- Available
- Nationwide Childrens Hospital Center
-
Columbus, Ohio, United States, 43210
- Available
- OSU Wexner MC James CH
-
Columbus, Ohio, United States, 43210
- Available
- The Ohio State University Hospitals Clinic The Ohio State University
-
Columbus, Ohio, United States, 43210
- Available
- The Ohio State University Hospitals Clinic
-
Columbus, Ohio, United States, 43210
- Available
- The Ohio State University Regulatory
-
Columbus, Ohio, United States, 43221
- Available
- The Ohio State University Comprehensive Cancer Center Ohio State UMC James Cancer Ct
-
Elyria, Ohio, United States, 44035
- Available
- Hematology Oncology Center, Inc.
-
-
Oregon
-
Portland, Oregon, United States, 97201
- Available
- Oregon Health Sciences University
-
Portland, Oregon, United States, 97239-3098
- Available
- Oregon Health and Science University
-
Portland, Oregon, United States, 97239
- Available
- OHSU
-
Portland, Oregon, United States, 97239
- Available
- Oregon Health and Science University
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19111
- Available
- Fox Chase Cancer Center
-
Philadelphia, Pennsylvania, United States, 19104
- Available
- Children's Hospital of Philadelphia
-
Philadelphia, Pennsylvania, United States, 19104 4399
- Available
- Childrens Hospital of Philadelphia CTRB 3006
-
Philadelphia, Pennsylvania, United States, 19104-4283
- Available
- Hospital of the University of Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104-4318
- Available
- Children's Hospital of Philadelphia Children's Hospital Of Phil(2)
-
Philadelphia, Pennsylvania, United States, 19104-4399
- Available
- Children s Hospital of Philadelphia Patient Treatment
-
Philadelphia, Pennsylvania, United States, 19104-4399
- Available
- Children s Hospital of Philadelphia
-
Philadelphia, Pennsylvania, United States, 19104-6149
- Available
- University of Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Available
- The Childrens Hospital of Philadelphia Children's Hosp Philadelphia
-
Philadelphia, Pennsylvania, United States, 19104
- Available
- The Childrens Hospital of Philadelphia Pediatric Oncology/Stem Cell T
-
Philadelphia, Pennsylvania, United States, 19104
- Available
- The Childrens Hospital of Philadelphia Regulatory
-
Philadelphia, Pennsylvania, United States, 19104
- Available
- University of Pennsylvania Health System CERL080AUS90
-
Philadelphia, Pennsylvania, United States, 19106
- Available
- Pennsylvania Oncology/Hemotology Dept.ofPenn. Onc./Hem.
-
Philadelphia, Pennsylvania, United States, 19107
- Available
- Thomas Jefferson University Hospital
-
Pittsburgh, Pennsylvania, United States, 15232
- Available
- University of Pittsburgh Cancer Institute
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Available
- Medical University of South Carolina MUSC
-
Greenville, South Carolina, United States, 29601
- Available
- Prisma Health Cancer Institute
-
-
South Dakota
-
Sioux Falls, South Dakota, United States, 57105
- Available
- Avera McKennan Hospital and University Health Center
-
-
Tennessee
-
Memphis, Tennessee, United States, 38104
- Available
- Methodist University Hospital Blood and Marrow Transplant
-
-
Texas
-
Dallas, Texas, United States, 75230
- Available
- Texas Cancer Center ( Medical City Dallas Hospital) TX Cancer Center
-
Dallas, Texas, United States, 75235
- Available
- Univof Texas Southwestern Medical Center, Dept of Pediatrics
-
Dallas, Texas, United States, 75390
- Available
- U of TX Southwestern Medical Center - SimmonsCompCancerCtr Satellite
-
Dallas, Texas, United States, 75390
- Available
- UT Southwestern Medical Center Pediatric Hematology/Onc
-
Dallas, Texas, United States, 75390
- Available
- UT Southwestern Medical Center UT SW Medical Ctr of Dallas
-
Fort Worth, Texas, United States, 76104
- Available
- Cook Children's
-
Houston, Texas, United States, 77030
- Available
- MD Anderson Cancer Center
-
Houston, Texas, United States, 77030
- Available
- Baylor College of Medicine
-
Houston, Texas, United States, 77030-2399
- Available
- Texas Children's Hospital Baylor College of Medicine
-
Houston, Texas, United States, 77030
- Available
- Houston Methodist Cancer Center Methodist Cancer Center (2)
-
Houston, Texas, United States, 77030
- Available
- Houston Methodist Hospital
-
Houston, Texas, United States, 77030
- Available
- MD Anderson Cancer Center/University of Texas MDACC
-
Houston, Texas, United States, 77030
- Available
- MD Anderson Cancer Center/University of Texas StudyCoordinator:CTKI258A2102
-
Houston, Texas, United States, 77030
- Available
- Methodist Hospital / Methodist Cancer Center Houston Methodist Hospital
-
San Antonio, Texas, United States, 78229
- Available
- Methodist Healthcare System
-
San Antonio, Texas, United States, 78229
- Available
- Methodist Hospital
-
-
Utah
-
Salt Lake City, Utah, United States, 84103
- Available
- University of Utah / Huntsman Cancer Institute Huntsman Cancer Cente
-
Salt Lake City, Utah, United States, 84113
- Available
- Primary Childrens Medical Center Oncology
-
Salt Lake City, Utah, United States, 84132
- Available
- LDS Hospital
-
-
Virginia
-
Charlottesville, Virginia, United States, 22908-0334
- Available
- University of Virginia Health Systems UVA
-
Richmond, Virginia, United States, 23298
- Available
- VCU Health Systems, MCV
-
-
Washington
-
Seattle, Washington, United States, 98109
- Available
- Fred Hutchinson Cancer Research Center Dept. of FHCRC
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53705-3611
- Available
- University of Wisconsin Hospital and Clinics
-
Madison, Wisconsin, United States, 53792
- Available
- University of Wisconsin Hospital and Clinics Hematopoietic Stem Cell Lab
-
Madison, Wisconsin, United States, 53792
- Available
- University of Wisconsin Hospital and Clinics
-
Madison, Wisconsin, United States, 53792
- Available
- University Wisconsin Children's Hospital
-
Milwaukee, Wisconsin, United States, 53226
- Available
- Childrens Hospital of Wisconsin
-
Milwaukee, Wisconsin, United States, 53226
- Available
- Medical College of Wisconsin Med College of WI (29)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
An independent request was received from a licensed physician. The patient has a serious or life-threatening disease or condition and there is no comparable or satisfactory alternative therapy available for diagnosis, monitoring, or treatment.
The patient is not eligible or able to enrol in a clinical trial or continue participation in such trial.
There is a potential patient benefit to justify the potential risk of the treatment use, and the potential risk is not unreasonable in the context of the disease or condition to be treated.
The patient must meet any other medical criteria established by the medical experts responsible for the product or by the health authority in the country of request (as applicable).
Provision of the product will not interfere with the initiation, conduct, or completion of a Novartis clinical trial or overall development program.
Managed Access provision is allowed per local laws/regulations.
Study Plan
How is the study designed?
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Novartis Pharmaceuticals, Novartis Pharmaceuticals
Study record dates
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CCTL019B2003I
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lymphoma
-
Zhejiang UniversityShanghai First Song Therapeutics Co., LtdNot yet recruitingHodgkin Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Diffuse Large B Cell Lymphoma | Gray Zone Lymphoma | NK/T Cell Lymphoma | Peripheral T Cell Lymphoma, Unspecified | Mediastinal B-Cell Diffuse Large Cell LymphomaChina
-
Marcela V. Maus, M.D.,Ph.D.RecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Refractory Non-Hodgkin Lymphoma | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | Non-hodgkin Lymphoma | High-grade B-cell Lymphoma | Grade 3b Follicular Lymphoma | Relapsed Non-Hodgkin LymphomaUnited States
-
SymBio PharmaceuticalsCompletedFollicular Lymphoma | Non-Hodgkin's Lymphoma | Lymphoma, Large Cell | Diffuse, Mantle Cell Lymphoma, Lymphoma | Large B-Cell, DiffuseJapan, Korea, Republic of
-
Novartis PharmaceuticalsBristol-Myers SquibbTerminatedNon-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone LymphomaItaly, Singapore, Australia, China, Germany, South Korea, Japan
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedFollicular Lymphoma | Mantle Cell Lymphoma | Non-Hodgkin Lymphoma | B-Cell Non-Hodgkin Lymphoma | Adult Diffuse Large B-Cell Lymphoma | T-Cell Non-Hodgkin LymphomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Lymphoproliferative Disorder | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Grade 3 Follicular... and other conditionsUnited States, Canada, Australia, Puerto Rico
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Mantle Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Marginal Zone Lymphoma | Recurrent Lymphoplasmacytic... and other conditionsUnited States, Canada
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedFollicular Lymphoma | Mantle Cell Lymphoma | Non-Hodgkin Lymphoma | Peripheral T-cell Lymphoma | Diffuse Large B-cell LymphomaUnited States
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular LymphomaUnited States, Belgium, Germany, France, Italy, Korea, Republic of, Spain, Turkey
-
Ruijin HospitalThe First Affiliated Hospital with Nanjing Medical University; Shanxi Province... and other collaboratorsNot yet recruitingLymphoma | Marginal Zone Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Diffuse Large B Cell Lymphoma | Mucosa-Associated Lymphoid Tissue Lymphoma | Intravascular Large B-Cell Lymphoma | Extranodal Lymphoma | NK/T-Cell Lymphoma, Nasal and Nasal-TypeChina
Clinical Trials on CTL019
-
Novartis PharmaceuticalsCompletedAcute Lymphoblastic LeukemiaBelgium, Germany, France, Austria, Canada, Italy, Japan, Norway, Spain
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawnB-cell Acute Lymphoblastic Leukemia | Refractory B-cell Acute Lymphoblastic Leukemia | Relapsed B-cell Acute Lymphoblastic Leukemia
-
Novartis PharmaceuticalsWithdrawnB-cell Acute Lymphoblastic Leukemia
-
Novartis PharmaceuticalsWithdrawnDiffuse Large B-Cell Lymphoma (DLBCL)
-
Children's Hospital of PhiladelphiaRecruitingCell Therapy | SLE | Systemic Lupus Erythematosus (SLE) | Lupus | Lupus Nephritis (LN) | CAR T Cell | CART19United States
-
Novartis PharmaceuticalsCompletedB-cell Acute Lymphoblastic Leukemia | Refractory B-cell Acute Lymphoblastic Leukemia | Relapsed B-cell Acute Lymphoblastic LeukemiaUnited States
-
University of CologneNovartisTerminated
-
Novartis PharmaceuticalsCompletedFollicular LymphomaUnited States, Spain, Australia, Germany, Italy, Austria, United Kingdom, France, Belgium, Japan, Netherlands, Norway
-
Novartis PharmaceuticalsRecruitingDiffuse Large B-cell Lymphoma | B-cell Acute Lymphoblastic LeukemiaJapan, Canada
-
Novartis PharmaceuticalsChildren's Oncology GroupActive, not recruitingB-Cell Acute Lymphoblastic LeukemiaUnited States, Canada, Norway, Italy, France, Denmark, United Kingdom, Belgium, Netherlands, Sweden, Spain